SCHEMBL25220187

SCHEMBL25220187

Fc1ccc(-c2nc3c([nH]2)CCCC3)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMPD3 Q9NY59 1/20 0.49
TNKS O95271 3/20 0.44
TNKS2 Q9H2K2 3/20 0.44
PARP1 P09874 2/20 0.44
WNT3A P56704 2/20 0.44
NPY5R Q15761 3/20 0.44
KDM4E B2RXH2 2/20 0.44
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
ALDH1A1 P00352 2/20 0.41
MAPK13 O15264 2/20 0.41
GCGR P47871 2/20 0.41
MAPK12 P53778 2/20 0.41
MAPK11 Q15759 2/20 0.41
MAPK14 Q16539 2/20 0.41
PKM P14618 1/20 0.41
PRKD3 O94806 1/20 0.41
MAP4K4 O95819 1/20 0.41
FRK P42685 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14153752 0.83 SMPD3 (0.49) SMPD3TNKSTNKS2PARP1WNT3A
SCHEMBL6861541 0.82 KMT2A (0.57) SMPD3TNKSTNKS2PARP1WNT3A
SCHEMBL11844688 0.79 TNKS2 (0.50) SMPD3TNKSTNKS2PARP1WNT3A
SCHEMBL7497847 0.78 TNKS (0.50) TNKSTNKS2PARP1WNT3AKDM4E
SCHEMBL15913449 0.76 KMT2A (0.44) SMPD3TNKSTNKS2PARP1WNT3A
SCHEMBL12490019 0.75 KDR (0.50) TNKSTNKS2PARP1KDM4ENPC1
SCHEMBL29930480 0.75 SMPD3 (0.43) SMPD3NPY5RALDH1A1KMT2AL3MBTL1
SCHEMBL28856074 0.75 SMPD3 (0.43) SMPD3NPY5RALDH1A1KMT2AL3MBTL1
SCHEMBL22408471 0.73 ALDH1A1 (0.49) SMPD3PARP1NPY5RKDM4ENPC1
SCHEMBL716608 0.70 KMT2A (0.52) KDM4ENPC1RAB9ASMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230192699-A1 COMPOUNDS AS CASEIN KINASE INHIBITORS Gritscience Biopharmaceuticals Co., Ltd. (CN) 2023-06-22 US disclosed
EP-4126878-A1 COMPOUNDS AS CASEIN KINASE INHIBITORS Gritscience Biopharmaceuticals Co., Ltd. (CN) 2023-02-08 EP disclosed
CN-115335057-A Method for inhibiting casein kinase 北京原基华毅生物科技有限公司 2022-11-11 CN disclosed
CN-115298183-A Compounds as casein kinase inhibitors 北京原基华毅生物科技有限公司 2022-11-04 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230192699-A1 COMPOUNDS AS CASEIN KINASE INHIBITORS CSNK2A3, CSNK1A1, CSNK1G3 SMPD3 2971/4885TNKS 1052/4885TNKS2 852/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.